[go: up one dir, main page]

ATE227520T1 - Ernährungszusammensetzung - Google Patents

Ernährungszusammensetzung

Info

Publication number
ATE227520T1
ATE227520T1 AT96202637T AT96202637T ATE227520T1 AT E227520 T1 ATE227520 T1 AT E227520T1 AT 96202637 T AT96202637 T AT 96202637T AT 96202637 T AT96202637 T AT 96202637T AT E227520 T1 ATE227520 T1 AT E227520T1
Authority
AT
Austria
Prior art keywords
source
present
omega
fatty acids
intensive care
Prior art date
Application number
AT96202637T
Other languages
English (en)
Inventor
John Alexander
Debora Gray
David A Mark
Nancy Schmelkin
Diana Twyman
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE227520T1 publication Critical patent/ATE227520T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96202637T 1995-09-20 1996-09-20 Ernährungszusammensetzung ATE227520T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/530,877 US5714472A (en) 1993-12-23 1995-09-20 Enternal formulation designed for optimized nutrient absorption and wound healing

Publications (1)

Publication Number Publication Date
ATE227520T1 true ATE227520T1 (de) 2002-11-15

Family

ID=24115344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96202637T ATE227520T1 (de) 1995-09-20 1996-09-20 Ernährungszusammensetzung

Country Status (7)

Country Link
US (1) US5714472A (de)
EP (1) EP0764405B1 (de)
AT (1) ATE227520T1 (de)
DE (1) DE69624768T2 (de)
DK (1) DK0764405T3 (de)
ES (1) ES2185744T3 (de)
PT (1) PT764405E (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2236089C (en) * 1995-11-24 2002-03-05 Loders-Croklaan B.V. Composition based on fish oil
US7629384B2 (en) * 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
US6200950B1 (en) 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US7001618B1 (en) 1999-07-09 2006-02-21 The Iams Company Nutritional composition for weight management
US6630159B2 (en) * 1999-02-23 2003-10-07 The Procter & Gamble Company Limiting weight gain of cats by feeding carbohydrate source that excludes rice
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
JP2004527501A (ja) * 2001-03-05 2004-09-09 ピー． アーネスト，スティーヴン 経腸処方
KR100441851B1 (ko) * 2001-06-04 2004-07-27 안강호 코로나 방전을 이용한 입자의 제조장치 및 그 제조방법
US6605310B2 (en) 2001-06-06 2003-08-12 Nestec S.A. Calorically dense liquid oral supplement
US20030104033A1 (en) * 2001-07-13 2003-06-05 Lai Chon-Si Enteral formulations
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
EP1633377B1 (de) * 2003-05-22 2007-03-21 N.V. Nutricia Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
DK1543735T3 (en) * 2003-12-20 2015-11-02 Nestec Sa FOOD COMPOSITION FOR HEALTH CARE
WO2005081964A2 (en) * 2004-02-23 2005-09-09 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
AU2005235309B2 (en) * 2004-04-19 2012-07-26 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20090105336A1 (en) * 2004-04-19 2009-04-23 Strategic Science & Technologies, Llc Beneficial Effects of Increasing Local Blood Flow
US9179702B2 (en) 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
CA2637852A1 (en) * 2006-01-31 2007-08-09 Nestec S.A. Nutritional composition for low birth weight infants
FR2918543A1 (fr) * 2007-07-09 2009-01-16 Routinsa Sa Compositions alimentaires enrichies en acides insatures a base de graines d'oleagineux.
CA2701179C (en) * 2007-10-04 2021-03-16 Nestec S.A. Compositions and methods for enhancing cognitive function
BRPI1012849A2 (pt) * 2009-05-11 2018-06-19 Nestec Sa lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
NZ597542A (en) 2009-06-24 2014-01-31 Strategic Science & Tech Llc Topical composition containing ibuprofen
WO2010149759A1 (en) 2009-06-24 2010-12-29 Basf Se Microparticles comprising a fat soluble fraction comprising dha and their production
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (de) 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topische zusammensetzung mit naproxen
EP2503906B1 (de) * 2009-11-25 2016-03-30 Nestec S.A. Ernährungszusammensetzungen mit einem bestandteil mit hohem proteingehalt und exogenen nukleotiden
EP2658551B1 (de) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Behandlung von erektionsstörungen und anderen indikationen
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
CN103347403B (zh) 2011-02-02 2016-04-20 雀巢产品技术援助有限公司 高蛋白质营养组合物及其制备和应用方法
WO2012138212A1 (en) * 2011-04-06 2012-10-11 N.V. Nutricia Food composition for intra-operative tube feeding
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
CN120436205A (zh) 2015-02-13 2025-08-08 马斯公司 包装宠物食物产品
WO2017134256A1 (en) * 2016-02-03 2017-08-10 Fresenius Kabi Deutschland Gmbh High caloric, high protein nutritional formula
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
US10743574B2 (en) * 2018-06-18 2020-08-18 Orgalife Nutrition Science Company Limited Oral/enteral nutritious foods and method of manufacturing the same
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
DE102018124227A1 (de) 2018-10-01 2020-04-02 sanaFactur GmbH Zubereitung zur Verbesserung körpereigener Wundheilung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (fr) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech Hydrolisat enzymatique total de proteines de lactoserum, obtention et application
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
FR2544613B1 (fr) * 1983-04-20 1985-10-25 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique, en reanimation et en therapeutique, renfermant une fraction proteique a base de trois types de minipeptides
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
EP0310639B1 (de) * 1987-02-20 1993-03-03 Shriners Hospitals For Crippled Children Omega-3-fettsäuren zur behandlung von traumatischen verwundungen
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients

Also Published As

Publication number Publication date
DK0764405T3 (da) 2003-02-10
PT764405E (pt) 2003-03-31
EP0764405A3 (de) 1998-04-29
DE69624768T2 (de) 2003-10-02
US5714472A (en) 1998-02-03
DE69624768D1 (de) 2002-12-19
EP0764405A2 (de) 1997-03-26
EP0764405B1 (de) 2002-11-13
ES2185744T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69624768D1 (de) Ernährungszusammensetzung
US5198468A (en) Essential fatty acid composition
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
DE69506642D1 (de) Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
PT780124E (pt) Composicoes farmaceuticas compreendendo uma alcanoil-l-carnitina em combinacao com acidos gordos poliinsaturados da serie omega-3 para a prevencao e o tratamento das doencas do metabolismo lipidico
DE69433713D1 (de) Für die behandlung neurologischer erkrankungen nützliche methoden und pharmazeutische zusammensetzungen
NZ250583A (en) Pharmaceutical, nutritional, or skin care compositions containing an ester of a cholesterol and fatty acid
ATE82684T1 (de) Mittel zur behandlung und zum schutz der haut.
ITMI951359A0 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
IE891819L (en) Essential fatty acid compositions
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
ES2216055T3 (es) Metodos para reducir o mantener niveles reducidos de lipidos en sangre usando composiciones de proteina ob.
ATE143261T1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
DE60008127D1 (de) Diät mit hohem lipidgehalt
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
AU633618B2 (en) Fatty acid therapy
AU7438287A (en) Omega-3 fatty acid aided reduction of cyclosporin mephrotoxicity
AU1300001A (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
ATE293895T1 (de) Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
DE3750426D1 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0764405

Country of ref document: EP

REN Ceased due to non-payment of the annual fee